Zu-cheng Ye
Fuzhou, 350112, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Design, synthesis, and biological evaluation of pyranone-carbamate hybrids as selective butyrylcholinesterase inhibitors with anti-neuroinflammatory activity for Alzheimer's disease.
Journal: Bioorganic chemistry
Published: February 25, 2026
Astrocytic CCL5 orchestrates CCR5-positive neuronal necroptosis in subarachnoid hemorrhage.
Journal: Journal of neuroinflammation
Published: September 28, 2025
AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy.
Journal: Pharmacological research
Published: February 10, 2025
A novel carbamate-based hybrid derivative with anti-neuroinflammatory properties as a selective butyrylcholinesterase inhibitor for Alzheimer's disease therapy.
Journal: Bioorganic chemistry
Published: January 25, 2025
D30 Alleviates β2-Microglobulin-Facilitated Neurotoxic Microglial Responses in Isoflurane/Surgery-Induced Cognitive Dysfunction in Aged Mice.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: July 25, 2024
Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of Galectin-3 ameliorates Aβ pathogenesis-induced neuroinflammation in 5 × FAD mice.
Journal: Life sciences
Published: July 11, 2024
Corrigendum to "Bexarotene enhances astrocyte phagocytosis via ABCA1-mediated pathways in a mouse model of subarachnoid hemorrhage" [Experimental Neurology 358 (2022) 114228].
Journal: Experimental neurology
Published: June 01, 2024
The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer's disease.
Journal: Neural regeneration research
Published: November 18, 2023
NeuroD1 administration ameliorated neuroinflammation and boosted neurogenesis in a mouse model of subarachnoid hemorrhage.
Journal: Journal of neuroinflammation
Published: June 24, 2023
Astrocytic connexin 43 deletion ameliorates SNI-induced neuropathic pain by reducing microglia activation.
Journal: Biochemical and biophysical research communications
Published: October 06, 2022
Last Updated: 09/26/2026